These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 8774653

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Low-dose oral granisetron (1 mg) plus intravenous dexamethasone: efficacy in gynecologic cancer patients receiving carboplatin-based chemotherapy.
    Markman M, Kennedy A, Webster K, Kulp B, Peterson G, Belinson J.
    Gynecol Oncol; 1998 Oct; 71(1):113-5. PubMed ID: 9784330
    [Abstract] [Full Text] [Related]

  • 3. The antiemetic efficacy of oral ondansetron plus intravenous dexamethasone in patients with gynecologic malignancies receiving carboplatin-based chemotherapy.
    Markman M, Kennedy A, Webster K, Peterson G, Kulp B, Belinson J.
    Gynecol Oncol; 2000 Jul; 78(1):43-6. PubMed ID: 10873408
    [Abstract] [Full Text] [Related]

  • 4. Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?
    Hamadani M, Chaudhary L, Awan FT, Khan JK, Kojouri K, Ozer H, Tfayli A.
    J Oncol Pharm Pract; 2007 Jun; 13(2):69-75. PubMed ID: 17873106
    [Abstract] [Full Text] [Related]

  • 5. Use of dexamethasone with 5-HT3-receptor antagonists for chemotherapy-induced nausea and vomiting.
    Perez EA.
    Cancer J Sci Am; 1998 Jun; 4(2):72-7. PubMed ID: 9532406
    [Abstract] [Full Text] [Related]

  • 6. [Granisetron, a new and potent antiemetic for treatment of cytostatic drug-induced vomiting in gynecological malignancies].
    Regidor PA, Schindler AE.
    Geburtshilfe Frauenheilkd; 1994 Jan; 54(1):51-4. PubMed ID: 8150251
    [Abstract] [Full Text] [Related]

  • 7. Antiemetic efficacy of granisetron plus dexamethasone in bone marrow transplant patients receiving chemotherapy and total body irradiation.
    Abbott B, Ippoliti C, Bruton J, Neumann J, Whaley R, Champlin R.
    Bone Marrow Transplant; 1999 Feb; 23(3):265-9. PubMed ID: 10084258
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the efficacy and safety of oral granisetron plus dexamethasone with intravenous ondansetron plus dexamethasone to control nausea and vomiting induced by moderate/severe emetogenic chemotherapy.
    Chiou TJ, Tzeng WF, Wang WS, Yen CC, Fan FS, Liu JH, Chen PM.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):729-36. PubMed ID: 11076429
    [Abstract] [Full Text] [Related]

  • 9. Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.
    Hesketh PJ, Gandara DR, Hesketh AM, Edelman M, Webber LM, McManus M, Hainsworth JD.
    Cancer J Sci Am; 1997 Oct; 3(3):180-3. PubMed ID: 9161784
    [Abstract] [Full Text] [Related]

  • 10. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
    Numbenjapon T, Sriswasdi C, Mongkonsritragoon W, Leelasiri A, Prayoonwiwat W.
    J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
    [Abstract] [Full Text] [Related]

  • 11. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P, Manusirivithaya S, Tangjitgamol S, Thavaramara T, Sukwattana P.
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [Abstract] [Full Text] [Related]

  • 12. Infusion of palonosetron plus dexamethasone for the prevention of chemotherapy-induced nausea and vomiting.
    Hajdenberg J, Grote T, Yee L, Arevalo-Araujo R, Latimer LA.
    J Support Oncol; 2006 Oct; 4(9):467-71. PubMed ID: 17080735
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of serotonin-receptor antagonist antiemetic therapy over successive courses of carboplatin-based chemotherapy.
    Markman MR, Peterson G, Kulp B, Markman M.
    Gynecol Oncol; 2002 Jun; 85(3):435-7. PubMed ID: 12051870
    [Abstract] [Full Text] [Related]

  • 14. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
    Sorbe BG, Berglind AM, Andersson H, Boman K, Högberg T, Hallgren M, Schmidt M.
    Cancer; 1998 Sep 01; 83(5):1022-32. PubMed ID: 9731907
    [Abstract] [Full Text] [Related]

  • 15. Randomized, double-blind, dose-finding study of dexamethasone in preventing acute emesis induced by anthracyclines, carboplatin, or cyclophosphamide:
    Italian Group For Antiemetic Research.
    J Clin Oncol; 2004 Feb 15; 22(4):725-9. PubMed ID: 14966097
    [Abstract] [Full Text] [Related]

  • 16. Antiemetic efficacy of single-dose oral granisetron (1 mg vs 2 mg) with moderately emetogenic chemotherapy.
    Hesketh PJ, Crews JR, Cohen R, Blackburn LM, Friedman CJ.
    Cancer J; 2000 Feb 15; 6(3):157-61. PubMed ID: 10882331
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial of once vs twice daily administration of intravenous granisetron with dexamethosone in patients receiving high-dose cyclophosphamide, thiotepa and carboplatin.
    Birch R, Weaver CH, Carson K, Buckner CD.
    Bone Marrow Transplant; 1998 Oct 15; 22(7):685-8. PubMed ID: 9818697
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of the use of granisetron, a selective 5-HT3 antagonist, versus a standard anti-emetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic-induced emesis. The Granisetron Study Group.
    Marty M.
    Eur J Cancer; 1990 Oct 15; 26 Suppl 1():S28-32. PubMed ID: 2169783
    [Abstract] [Full Text] [Related]

  • 19. Low-dose intravenous ondansetron (8 mg) plus dexamethasone: an effective regimen for the control of carboplatin-induced emesis.
    Markman M, Kennedy A, Webster K, Peterson G, Kulp B, Belinson J.
    J Cancer Res Clin Oncol; 1997 Oct 15; 123(4):224-6. PubMed ID: 9177495
    [Abstract] [Full Text] [Related]

  • 20. [Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer].
    Fujii T, Nakata N, Shiroyama Y, Sawasaki T, Tanimoto H, Shigemasa K, Kioka H, Naito H.
    Gan To Kagaku Ryoho; 1997 Dec 15; 24(15):2245-52. PubMed ID: 9422069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.